Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease.

Abstract:

:Amyloid-β protein (Aβ) accumulates in the neurons of Alzheimer's disease (AD) patients at an early stage of the disease. Recently, we found that Aβ with a toxic turn at positions 22 and 23 accumulates in neurons in AD brain. Here, we studied the accumulation of Aβ, toxic turn Aβ and high-molecular-weight Aβ oligomers in presenilin 1 (PS1) gene-transfected SH-SY5Y cells as well as in the brains of 3xTg-AD mice and AD patients. Immunostaining revealed that accumulation of toxic turn Aβ was promoted in G384A- and I143T-mutant PS1-transfected cells and further enhanced by co-transfection of cells with the Aβ-precursor protein (AβPP) gene. In contrast, accumulation of high-molecular-weight Aβ oligomers was promoted in mutant PS1 cells but attenuated by co-transfection of cells with the AβPP gene. Toxic turn Aβ was detected in the neurons of 3xTg-AD mice aged 2 months, when the mice were cognitively unimpaired. In contrast, high-molecular-weight Aβ oligomers were detected in the neurons of 7-month-old mice, when memory dysfunction is apparent. Furthermore, immunostaining and western blotting for Rab4, Rab6 and GRP78 revealed increased levels of these proteins in mutant PS1 cells and their accumulation in the neurons of 3xTg-AD mice. Remarkably, GRP78 immunoreactivity was increased at 2 months of age. Double-label immunostaining of AD brain revealed an apparent association between toxic turn Aβ and GRP78, an endoplasmic reticulum (ER) stress marker. Intraneuronal accumulation of toxic turn Aβ may be associated with ER stress in the brains of AD model mice and AD patients at an early stage.

journal_name

Curr Alzheimer Res

authors

Soejima N,Ohyagi Y,Nakamura N,Himeno E,Iinuma KM,Sakae N,Yamasaki R,Tabira T,Murakami K,Irie K,Kinoshita N,LaFerla FM,Kiyohara Y,Iwaki T,Kira J

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

11-20

issue

1

eissn

1567-2050

issn

1875-5828

pii

CAR-EPUB-20120830-2

journal_volume

10

pub_type

杂志文章
  • Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells.

    abstract::Alzheimer's disease (AD) is a progressive degenerative disorder of the brain and is the most common form of dementia. To-date no simple, inexpensive and minimally invasive procedure is available to confirm with certainty the early diagnosis of AD prior to the manifestations of symptoms characteristic of the disease. T...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/1567205011666140618103827

    authors: François M,Leifert W,Martins R,Thomas P,Fenech M

    更新日期:2014-01-01 00:00:00

  • Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer's disease.

    abstract::Amyloid oligomers have a critical function in the pathologic processes of various amyloidoses, such as Alzheimer's disease (AD), Parkinson disease (PD), Huntington's disease, prion-related diseases, type 2 diabetes, and hereditary renal amyloidosis. Our previous reports demonstrated that a conformation-dependent oligo...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/15672050113106660176

    authors: Zhao M,Wang SW,Wang YJ,Zhang R,Li YN,Su YJ,Zhou WW,Yu XL,Liu RT

    更新日期:2014-01-01 00:00:00

  • Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline.

    abstract::Memory loss is a prominent health concern, second only to heart disease for older individuals. Docosahexaenoic acid (DHA), the principle omega-3 fatty acid in brain and heart, plays an important role in neural and cardiac function. Decreases in plasma DHA are associated with cognitive decline in healthy elderly and Al...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/156720510791050911

    authors: Yurko-Mauro K

    更新日期:2010-05-01 00:00:00

  • Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.

    abstract::Amyloid beta (Aβ) binding alcohol dehydrogenase (ABAD) is a cellular cofactor for promoting (Aβ)-mediated mitochondrial and neuronal dysfunction, and cognitive decline in transgenic Alzheimer's disease (AD) mouse models. Targeting mitochondrial ABAD may represent a novel therapeutic strategy against AD. Here, we repor...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/1567205011666140130150108

    authors: Valaasani KR,Sun Q,Hu G,Li J,Du F,Guo Y,Carlson EA,Gan X,Yan SS

    更新日期:2014-02-01 00:00:00

  • Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.

    abstract::Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the growing population of elderly people. A characteristic of AD is the accumulation of plaques in the brain of AD patients, and theses plaques mainly consist of aggregates of amyloid beta-peptide (Abeta). All converging lines of evidence sugg...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/156720508784533321

    authors: Cerpa W,Dinamarca MC,Inestrosa NC

    更新日期:2008-06-01 00:00:00

  • Relationship Between the Japanese Version of the Montreal Cognitive Assessment and PET Imaging in Subjects with Mild Cognitive Impairment.

    abstract:BACKGROUND:The Montreal Cognitive Assessment (MoCA) test has high sensitivity and specificity for detecting mild cognitive impairment or early dementia. How the MoCA score relates to findings of positron emission tomography imaging, however, remains unclear. OBJECTIVE:This prospective study examined the relationship b...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/1567205016666190805155230

    authors: Eguchi A,Kimura N,Aso Y,Yabuuchi K,Ishibashi M,Hori D,Sasaki Y,Nakamichi A,Uesugi S,Jikumaru M,Sumi K,Shimomura T,Matsubara E

    更新日期:2019-01-01 00:00:00

  • Alzheimer's Disease and NQO1: Is there a Link?

    abstract:BACKGROUND:Alzheimer's disease (AD) is a neurodegenerative disease characterised by a progressive decline in cognitive function and represents a major healthcare challenge worldwide. Increasing evidence indicates that mitochondrial dysfunction mediated oxidative stress plays a significant role in the pathophysiological...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/1567205014666170203095802

    authors: Chhetri J,King AE,Gueven N

    更新日期:2018-01-01 00:00:00

  • Amyloid-beta peptide 1-42 causes microtubule deregulation through N-methyl-D-aspartate receptors in mature hippocampal cultures.

    abstract::Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder among the elderly. Nmethyl- D-aspartate receptor (NMDAR) overactivation has been implicated in early synaptic dysfunction that precedes late neurodegeneration in AD. Moreover, oligomers of amyloid-beta peptide (Aβ) 1-42 are considered t...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/156720512802455322

    authors: Mota SI,Ferreira IL,Pereira C,Oliveira CR,Rego AC

    更新日期:2012-09-01 00:00:00

  • Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjects.

    abstract::A crucial need exists for reliable Alzheimer's disease (AD) diagnostic and prognostic tests. Given its intimate communication with the brain, the cerebrospinal fluid (CSF) has been surveyed intensively for reliable AD biomarkers. The heterogeneity of AD pathology and the unavoidable difficulties associated with the cl...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/156720509788929318

    authors: Maarouf CL,Andacht TM,Kokjohn TA,Castaño EM,Sue LI,Beach TG,Roher AE

    更新日期:2009-08-01 00:00:00

  • The role of α-synuclein in neurodegenerative diseases: from molecular pathways in disease to therapeutic approaches.

    abstract::Parkinson disease (PD) is the second most prevalent neurodegenerative disorder after Alzheimer's disease (AD). The formation of the cytoplasmic inclusions named "Lewy bodies" in the brain, considered to be a marker for neuronal degeneration in PD and dementia with Lewy bodies. However, Lewy bodies (LBs) are also obser...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/1567205011310060002

    authors: Al-Mansoori KM,Hasan MY,Al-Hayani A,El-Agnaf OM

    更新日期:2013-07-01 00:00:00

  • Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and Dementia.

    abstract::Neurodegenerative diseases may directly affect memory performance, thus leading to functional impairments. An increasing body of evidence suggests an association between dietary intake of omega-3 fatty acids and memory functioning in animal models as well as in human studies. Recent evidence supports a potential benef...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/1567205013666160602235520

    authors: Knöchel C,Voss M,Gruter F,Alves GS,Matura S,Sepanski B,Stablein M,Kraft D,Prvulovic D,Carvalho AF,Reif A,Oertel-Knochel V

    更新日期:2017-01-01 00:00:00

  • The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View.

    abstract::Lipids participate in Amyloid Precursor Protein (APP) trafficking and processing - important factors in the initiation of Alzheimer's disease (AD) pathogenesis and influence the formation of neurotoxic β-amyloid (Aβ) peptides. An important risk factor, the presence of ApoE4 protein in AD brain cells binds the lipids t...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/1567205015666180911151716

    authors: Penke B,Paragi G,Gera J,Berkecz R,Kovács Z,Crul T,VÍgh L

    更新日期:2018-01-01 00:00:00

  • Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

    abstract::Down syndrome (DS) is the most common non-lethal genetic condition that affects approximately 1 in 700 births in the United States of America. DS is characterized by complete or segmental chromosome 21 trisomy, which leads to variable intellectual disabilities, progressive memory loss, and accelerated neurodegeneratio...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/1567205012666150921095505

    authors: Hamlett ED,Boger HA,Ledreux A,Kelley CM,Mufson EJ,Falangola MF,Guilfoyle DN,Nixon RA,Patterson D,Duval N,Granholm AC

    更新日期:2016-01-01 00:00:00

  • Mitochondrial dysfunction and Alzheimer's disease.

    abstract::Mitochondrial dysfunction has been implicated in causing metabolic abnormalities in Alzheimer's disease (AD). The searches for mitochondrial DNA variants associated with AD susceptibility have generated conflicting results. The age-related accumulation of somatic mitochondrial DNA deletion has been suggested to play a...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/156720506779025215

    authors: Chen X,Stern D,Yan SD

    更新日期:2006-12-01 00:00:00

  • Synaptic fatigue is more pronounced in the APP/PS1 transgenic mouse model of Alzheimer's disease.

    abstract::To search for potential mechanism that might alter synaptic transmission following Abeta increase we have examined the presynaptic component of transmitter release. As parameters of synaptic transmission that might underlie presynaptic mechanisms, we have used paired-pulse facilitation (PPF), post-tetanic potentiation...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/1567205053585936

    authors: Zhang H,Gong B,Liu S,Fa' M,Ninan I,Staniszewski A,Arancio O

    更新日期:2005-04-01 00:00:00

  • A genomic approach to investigate neuronal apoptosis.

    abstract::Apoptosis has been postulated to play a possible causal role in the onset of Alzheimer's disease due to shortage of trophic supply, deafferentation and excessive production of free radicals. Many experiments in the past have demonstrated the requirement of de novo gene expression during neuronal apoptosis. In view of ...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/156720506778249416

    authors: Cavallaro S,Calissano P

    更新日期:2006-09-01 00:00:00

  • Detection of Amyloid-beta aggregates in body fluids: a suitable method for early diagnosis of Alzheimer's disease?

    abstract::Today, the most reliable diagnosis for Alzheimer's disease (AD) is the post mortem identification of amyloid plaques, consisting of the Amyloid-beta (Abeta) peptide, (and neurofibrillary tangles) in the brain of the patient. Great efforts are being made to identify reliable biomarkers for AD that are suitable for mini...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/156720509788486536

    authors: Funke SA,Birkmann E,Willbold D

    更新日期:2009-06-01 00:00:00

  • An Optimal Approach for Selecting Discriminant Regions for the Diagnosis of Alzheimer's Disease.

    abstract::In this work, we present a fully automatic computer-aided diagnosis method for the early diagnosis of the Alzheimer's disease. We study the distance between classes (labelled as normal controls and possible Alzheimer's disease) calculated in 116 regions of the brain using the Welchs's t-test. We select the regions wit...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/1567205013666160415154852

    authors: Salas-Gonzalez D,Segovia F,Martínez-Murcia FJ,Lang EW,Gorriz JM,Ramırez J

    更新日期:2016-01-01 00:00:00

  • Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.

    abstract:BACKGROUND/OBJECTIVES:Increasing evidence suggests the importance of neuroinflammation in the pathogenesis of Alzheimer's disease (AD), which is a complex neurodegenerative disorder. Complement activation occurs in the brain of patients with AD and seems to contribute to an important local inflammatory state. Increased...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/1567205013666161013091934

    authors: Zorzetto M,Datturi F,Divizia L,Pistono C,Campo I,De Silvestri A,Cuccia M,Ricevuti G

    更新日期:2017-01-01 00:00:00

  • Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease.

    abstract::Accumulating evidence has suggested the involvement of oxidative stress in the pathogenesis of Alzheimer's disease (AD). The main endogenous antioxidant, glutathione (GSH), has been shown to decline with ageing and in several age-related degenerative diseases, including AD. Potential options for replenishing GSH level...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/1567205012666150302160308

    authors: Peter C,Braidy N,Zarka M,Welch J,Bridge W

    更新日期:2015-01-01 00:00:00

  • Drusen in the Peripheral Retina of the Alzheimer's Eye.

    abstract:BACKGROUND:Recent work on Alzheimer's disease (AD) diagnosis focuses on neuroimaging modalities; however, these methods are expensive, invasive, and not available to all patients. Ocular imaging of biomarkers, such as drusen in the peripheral retina, could provide an alternative method to diagnose AD. OBJECTIVE:This s...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/1567205015666180123122637

    authors: Ukalovic K,Cao S,Lee S,Tang Q,Beg MF,Sarunic MV,Hsiung GR,Mackenzie IR,Hirsch-Reinshagen V,Cui JZ,Matsubara JA

    更新日期:2018-01-01 00:00:00

  • Tau aggregation is a therapeutic target for Alzheimer's disease.

    abstract::Based on the amyloid hypothesis, studies for AD therapy have been mostly focused on removing β-amyloid. Recent results of amyloid immunotherapy raised the question whether β-amyloid is sufficient target for AD therapy. Neurofibrillary tangles (NFTs), which contain hyperphosphorylated tau, are another pathological hall...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/156720510793611600

    authors: Takashima A

    更新日期:2010-12-01 00:00:00

  • Oral Administration of Thioflavin T Prevents Beta Amyloid Plaque Formation in Double Transgenic AD Mice.

    abstract::Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the fourth leading cause of death in the United States and most common cause of adult-onset dementia. The major hallmarks of AD are the formation of senile amyloid plaques made of beta amyloid and neurofibrillary tangles (NFT) which are primarily...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/156720501209151019105647

    authors: Sarkar S,Raymick J,Ray B,Lahiri DK,Paule MG,Schmued L

    更新日期:2015-01-01 00:00:00

  • Calcium signalling toolkits in astrocytes and spatio-temporal progression of Alzheimer's disease.

    abstract::Pathological remodelling of astroglia represents an important component of the pathogenesis of Alzheimer's disease (AD). In AD astrocytes undergo both atrophy and reactivity; which may be specific for different stages of the disease evolution. Astroglial reactivity represents the generic defensive mechanism, and inhib...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/1567205013666151116130104

    authors: Lim D,Rodríguez-Arellano JJ,Parpura V,Zorec R,Zeidán-Chuliá F,Genazzani AA,Verkhratsky A

    更新日期:2016-01-01 00:00:00

  • Amyloid beta conformation in aqueous environment.

    abstract::Amyloid beta peptide (Abeta), 42-residue peptide and its variations, is known to form amyloid fibrils in Alzheimer's disease. Solid-state NMR study reveals a parallel beta-sheet structure in the Abeta fibrils. The atomic level structure of Abeta in aqueous environment, however, has not been determined, because of its ...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/156720508786898424

    authors: Takano K

    更新日期:2008-12-01 00:00:00

  • Alzheimer's disease: spect and pet tracers for beta-amyloid imaging.

    abstract::The definite diagnosis of Alzheimer's disease (AD) is based on the detection of beta amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) - which are the pathological hallmarks of the disease- in the postmortem brains. Although regional Cerebral Blood Flow (rCBF) and Cerebral Glucose Metabolism (CGM) abnormalities ...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/156720510792231757

    authors: Valotassiou V,Archimandritis S,Sifakis N,Papatriantafyllou J,Georgoulias P

    更新日期:2010-09-01 00:00:00

  • Neuropsychiatric Disturbances in Mild Cognitive Impairment (MCI): A Systematic Review of Population-Based Studies.

    abstract::Mild cognitive impairment (MCI) is a nosological entity associated with a higher risk of developing dementia. Previous evidence indicates that behavioral and psychological symptoms of dementia (BPSDs) frequently occur in individuals of MCI. These neuropsychiatric manifestations may predict conversion to dementia. Howe...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/1567205013666160502123129

    authors: Köhler CA,Magalhaes TF,Oliveira JM,Alves GS,Knochel C,Oertel-Knöchel V,Pantel J,Carvalho AF

    更新日期:2016-01-01 00:00:00

  • Why so few drugs for Alzheimer's disease? Are methods failing drugs?

    abstract::Recent studies of Alzheimer's disease (AD) and other neuropsychiatric drug developments raise questions whether failures of some drugs occur due to flaws in methods. In three case studies of recent AD drug development failures with phenserine, metrifonate, and tarenflurbil we identified methodological lapses able to a...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章,评审

    doi:10.2174/156720510793499075

    authors: Becker RE,Greig NH

    更新日期:2010-11-01 00:00:00

  • Brain perfusion SPECT with Brodmann areas analysis in differentiating frontotemporal dementia subtypes.

    abstract::Despite the known validity of clinical diagnostic criteria, significant overlap of clinical symptoms between Frontotemporal dementia (FTD) subtypes exists in several cases, resulting in great uncertainty of the diagnostic boundaries. We evaluated the perfusion between FTD subtypes using brain perfusion (99m)Tc-HMPAO S...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/1567205011666141107125104

    authors: Valotassiou V,Papatriantafyllou J,Sifakis N,Tzavara C,Tsougos I,Psimadas D,Kapsalaki E,Fezoulidis I,Hadjigeorgiou G,Georgoulias P

    更新日期:2014-01-01 00:00:00

  • Differential Expression of Ribosomal Genes in Brain and Blood of Alzheimer's Disease Patients.

    abstract::Changes in rRNA and rDNA expression have been associated with cellular and organism aging and have been linked to Alzheimer's disease (AD) pathogenesis. In this study, we investigated the mRNA expression of ribosomal genes (28S/18S) and β-amyloid precursor protein (APP) in different post mortem brain tissue regions (t...

    journal_title:Current Alzheimer research

    pub_type: 杂志文章

    doi:10.2174/1567205012666151027124017

    authors: Rasmussen L,de Labio RW,Viani GA,Chen E,Villares J,Bertolucci PH,Minett TS,Turecki G,Cecyre D,Drigo SA,Smith MC,Payao SL

    更新日期:2015-01-01 00:00:00